- Home
- RMTI vs CALC Comparison
RMTI vs CALC Comparison
Compare RMTI & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- CALC
- Stock Information
- Founded
- RMTI 1994
- CALC 2011
- Country
- RMTI United States
- CALC United States
- Employees
- RMTI N/A
- CALC N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- CALC Health Care
- Exchange
- RMTI Nasdaq
- CALC Nasdaq
- Market Cap
- RMTI 33.0M
- CALC 26.7M
- IPO Year
- RMTI 1998
- CALC N/A
- Fundamental
- Price
- RMTI $0.91
- CALC $1.67
- Analyst Decision
- RMTI Strong Buy
- CALC Strong Buy
- Analyst Count
- RMTI 2
- CALC 3
- Target Price
- RMTI $4.00
- CALC $16.33
- AVG Volume (30 Days)
- RMTI 163.6K
- CALC 16.3K
- Earning Date
- RMTI 08-07-2025
- CALC 08-11-2025
- Dividend Yield
- RMTI N/A
- CALC N/A
- EPS Growth
- RMTI N/A
- CALC N/A
- EPS
- RMTI N/A
- CALC N/A
- Revenue
- RMTI $97,727,000.00
- CALC N/A
- Revenue This Year
- RMTI N/A
- CALC N/A
- Revenue Next Year
- RMTI $11.16
- CALC N/A
- P/E Ratio
- RMTI N/A
- CALC N/A
- Revenue Growth
- RMTI 12.82
- CALC N/A
- 52 Week Low
- RMTI $0.86
- CALC $1.43
- 52 Week High
- RMTI $5.15
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- RMTI 39.80
- CALC 45.93
- Support Level
- RMTI $0.91
- CALC $1.68
- Resistance Level
- RMTI $1.00
- CALC $1.79
- Average True Range (ATR)
- RMTI 0.05
- CALC 0.08
- MACD
- RMTI -0.00
- CALC -0.00
- Stochastic Oscillator
- RMTI 11.71
- CALC 34.48
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.